Fujirebio Holdings, a subsidiary of H.U. Group Holdings, has purchased ADx NeuroSciences for $42 million.
ADx NeuroSciences specializes in generating antibodies and developing assays for pharma companies.
“By welcoming ADx NeuroSciences into the Fujirebio group of companies, Fujirebio will be able to expand its antibody supply business and contract development and manufacturing offerings in the neurodegenerative field to our partners globally,” says Goki Ishikawa, CEO of Fujirebio Holdings. “We are excited to work together with the ADx NeuroSciences team to expand the global neurodegeneration biomarker testing market.”